JP2018521995A5 - - Google Patents

Download PDF

Info

Publication number
JP2018521995A5
JP2018521995A5 JP2017566402A JP2017566402A JP2018521995A5 JP 2018521995 A5 JP2018521995 A5 JP 2018521995A5 JP 2017566402 A JP2017566402 A JP 2017566402A JP 2017566402 A JP2017566402 A JP 2017566402A JP 2018521995 A5 JP2018521995 A5 JP 2018521995A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
drinking water
medicinal
obtainable
isoxazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017566402A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018521995A (ja
JP6933983B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/064449 external-priority patent/WO2016207234A1/en
Publication of JP2018521995A publication Critical patent/JP2018521995A/ja
Publication of JP2018521995A5 publication Critical patent/JP2018521995A5/ja
Application granted granted Critical
Publication of JP6933983B2 publication Critical patent/JP6933983B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017566402A 2015-06-23 2016-06-22 衛生化飲料水と共に使用するためのビタミンeを含有するイソオキサゾリン溶液 Active JP6933983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15173454 2015-06-23
EP15173454.8 2015-06-23
PCT/EP2016/064449 WO2016207234A1 (en) 2015-06-23 2016-06-22 Isoxazoline solution containing vitamin e for use with sanitized drinking water

Publications (3)

Publication Number Publication Date
JP2018521995A JP2018521995A (ja) 2018-08-09
JP2018521995A5 true JP2018521995A5 (enExample) 2019-07-25
JP6933983B2 JP6933983B2 (ja) 2021-09-08

Family

ID=53488226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017566402A Active JP6933983B2 (ja) 2015-06-23 2016-06-22 衛生化飲料水と共に使用するためのビタミンeを含有するイソオキサゾリン溶液

Country Status (10)

Country Link
US (3) US20180169073A1 (enExample)
EP (1) EP3313400B1 (enExample)
JP (1) JP6933983B2 (enExample)
CN (1) CN107750159B (enExample)
BR (1) BR112017027855B1 (enExample)
ES (1) ES2920394T3 (enExample)
HU (1) HUE059228T2 (enExample)
MX (1) MX383746B (enExample)
PL (1) PL3313400T3 (enExample)
WO (1) WO2016207234A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
KR102668200B1 (ko) * 2015-10-28 2024-05-23 주식회사유한양행 지속형 fgf21 융합 단백질 및 이를 포함하는 약학적 조성물
UY40429A (es) 2016-02-24 2023-10-13 Boehringer Ingelheim Animal Health Usa Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
AU2018385766B2 (en) 2017-12-15 2022-12-01 Tarsus Pharmaceuticals, Inc. Isoxazoline parasiticide formulations and methods for treating blepharitis
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
CA3164924A1 (en) 2019-12-18 2021-06-24 Elanco Tiergesundheit Ag Isoxazoline derivatives as pesticides
AU2021311722A1 (en) 2020-07-24 2023-02-02 Elanco Us Inc. Process for making an isoxazoline compound and intermediate thereof
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations
KR20230162001A (ko) * 2021-03-11 2023-11-28 인 더 보울 애니멀 헬스, 인크. 갯과에서 진드기 감염을 방제하기 위한 경구용 갯과 사료 및 방법
CN114306231B (zh) * 2021-12-29 2023-03-24 天津市中升挑战生物科技有限公司 一种氟雷拉纳杀虫剂及其制备方法和应用
CN115266988A (zh) * 2022-08-01 2022-11-01 江苏慧聚药业股份有限公司 一种氟雷拉钠有关物质的检测方法
CN117064851B (zh) * 2023-09-20 2026-02-17 中国农业大学 一种异噁唑啉类驱虫药制剂的制备方法
CN118477040B (zh) * 2024-04-11 2025-02-25 河北威远药业有限公司 一种氟雷拉纳溶液的制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962488A (en) * 1998-04-08 1999-10-05 Roberts Laboratories, Inc. Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
ATE473944T1 (de) * 2000-06-27 2010-07-15 Procter & Gamble Mittel zur wasserbehandlung
US20050005868A1 (en) * 2003-07-11 2005-01-13 Shepard Allan T. Animal drinking water production
AU2005219788B2 (en) 2004-03-05 2010-06-03 Nissan Chemical Corporation Isoxazoline-substituted benzamide compound and noxious organism control agent
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
JP2007319124A (ja) * 2006-06-02 2007-12-13 Nippon Tablet Kk 健康食品
US8372867B2 (en) 2007-04-10 2013-02-12 Bayer Cropscience Ag Insecticidal aryl isoxazoline derivatives
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
ES2549731T3 (es) 2007-06-27 2015-11-02 E. I. Du Pont De Nemours And Company Método para el control de plagas en animales
US20090024541A1 (en) * 2007-07-20 2009-01-22 Gary Kremen Power purchase methods, agreements and financial instruments for tax-advantaged financing residential renewable energy equipment
TWI556741B (zh) * 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
CN102088856B (zh) * 2008-07-09 2015-11-25 巴斯夫欧洲公司 包含异*唑啉化合物的杀虫活性混合物i
US7951404B2 (en) 2008-07-11 2011-05-31 Sanosil Ag Concentrate for preparing a disinfectant and methods for its preparation and use
ES2442342T3 (es) 2008-12-18 2014-02-11 Novartis Ag Derivados de las isoxazolinas y su uso como pesticida
CA2747354C (en) 2008-12-19 2016-12-06 Novartis Ag Isoxazoline derivatives and their use as pesticide
EP3078664B1 (en) 2009-12-17 2019-02-20 Merial Inc. Antiparasitic dihydroazole compositions
JP2013518084A (ja) * 2010-02-01 2013-05-20 ビーエーエスエフ ソシエタス・ヨーロピア 有害動物を駆除するための置換されたケトン性イソオキサゾリン化合物および誘導体
MX2012011549A (es) 2010-04-08 2013-01-29 Ah Usa 42 Llc Derivados de 3,5-difenil-isoxazolina sustituida como insecticidas y acaricidas.
WO2012155352A1 (en) 2011-05-19 2012-11-22 Eli Lilly And Company Dihydroisoxazole compounds, parasiticidal uses and formulations thereof
KR20140054302A (ko) 2011-08-25 2014-05-08 신젠타 파티서페이션즈 아게 살곤충 화합물로서의 이속사졸린 유도체
WO2013026695A1 (en) 2011-08-25 2013-02-28 Syngenta Participations Ag Isoxazoline derivatives as insecticidal compounds
PL3172964T3 (pl) * 2011-09-12 2021-03-08 Boehringer Ingelheim Animal Health USA Inc. Kompozycje przeciwpasożytniczne zawierające izoksazolinową substancję czynną, sposób i ich zastosowania
CA2924537C (en) 2013-09-30 2018-01-16 Todd P. Foster Long-acting spiro-isoxazoline formulations
US9371293B2 (en) 2013-10-25 2016-06-21 Sumitomo Chemical Company, Limited Isoxazoline compound composition
DK3063144T3 (da) 2013-11-01 2021-10-25 Boehringer Ingelheim Animal Health Usa Inc Antiparasitære og pesticid-isoxazolinforbindelser
WO2015086551A1 (en) * 2013-12-10 2015-06-18 Intervet International B.V. Antiparasitic use of isoxazoline compounds
PT3082806T (pt) * 2013-12-20 2021-06-04 Intervet Int Bv Utilização de derivados de isoxazolina para o tratamento ou a prevenção de infestações de artrópodes em aves
RU2688919C1 (ru) * 2013-12-20 2019-05-23 Интервет Интернэшнл Б.В. Изоксазолиновые композиции и их применение в провилактике или лечении паразитарных инвазий животных
US20170354593A1 (en) * 2014-11-03 2017-12-14 Zoetis Services Llc Palatable chewable veterinary composition

Similar Documents

Publication Publication Date Title
JP2018521995A5 (enExample)
JP2014504586A5 (enExample)
JP2014506249A5 (enExample)
RU2016129474A (ru) Изоксазолиновые композиции
JP2016540028A5 (enExample)
JP2017538767A5 (enExample)
RU2013135280A (ru) Состав изоксазолина для местного и наружного применения
JP2013510124A5 (enExample)
RU2015123737A (ru) Производство полупластичных фармацевтических препаратов
JP2013545785A5 (enExample)
JP2005508967A5 (enExample)
PE20190328A1 (es) Compuestos de carfilzomib pegilados
RU2013135415A (ru) Изоксазолиновый состав, содержащий гликофурол для наружного и местного применения
SI2978752T1 (en) 6- (5-Hydroxy-1H-pyrazol-1-yl) nicotinamide derivatives and their use as inhibitors of PHD
JO3430B1 (ar) مشتقات حمض أميني جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها
RU2010143857A (ru) Тетрагидрофенантридиноны и тетрагидроциклопентахинолиноны в качестве ингибриторов parp и ингибиторов полимеризации тубулина
EP2987791A4 (en) Novel 3- (4- (benzyloxy) phenyl) hexadecanoic acid derivative, process for the preparation thereof, and pharmaceutical composition for the prevention and treatment of metabolic disorders, therefore, as an active ingredient
IL274065B2 (en) Injectable isoxazoline pharmaceutical compounds and their antiparasitic use
RU2016123144A (ru) Сложноэфирное хиральное соединение (n-замещенный имидазол)-карбоновой кислоты, содержащее простую эфирную боковую цепь, его получение и применение
RU2015150120A (ru) Соединение дикарбоновой кислоты
AR081821A1 (es) Antranilamidas sustituidas con triazol como plaguicidas
AR037350A1 (es) Derivados de piperidina, proceso para preparar estos compuestos, composicion farmaceutica, y uso de estos compuestos para la manufactura de un medicamento util para el tratamiento de una enfermedad mediada por ccr5 (tal como artritis reumatoidea)
RU2481344C2 (ru) Замещенные (оксазолидинон-5-ил-метил)-2-тиофен-карбоксамиды и их применение в сфере свертывания крови
EA201590474A1 (ru) ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ КОМПОЗИТНЫХ КАПСУЛ, ВКЛЮЧАЮЩИХ ИРБЕСАРТАН И ИНГИБИТОР ГМГ-КоА РЕДУКТАЗЫ
NZ722727A (en) 1-(3-aminopropyl) substituted cyclic amine compounds, preparation method therefor, and pharmaceutical compositions and uses thereof